The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Enzymes of the mevalonate pathway of isoprenoid biosynthesis
Open accessAbstract
The mevalonate pathway accounts for conversion of acetyl-CoA to isopentenyl 5-diphosphate, the versatile precursor of polyisoprenoid metabolites and natural products. The pathway functions in most eukaryotes, archaea, and some eubacteria. Only recently has much of the functional and structural basis for this metabolism been reported. The biosynthetic acetoacetyl-CoA thiolase and HMG-CoA synthase reactions rely on key amino acids that are different but are situated in active sites that are similar throughout the family of initial condensation enzymes. Both bacterial and animal HMG-CoA reductases have been extensively studied and the contrasts between these proteins and their interactions with statin inhibitors defined. The conversion of mevalonic acid to isopentenyl 5-diphosphate involves three ATP-dependent phosphorylation reactions. While bacterial enzymes responsible for these three reactions share a common protein fold, animal enzymes differ in this respect as the recently reported structure of human phosphomevalonate kinase demonstrates. There are significant contrasts between observations on metabolite inhibition of mevalonate phosphorylation in bacteria and animals. The structural basis for these contrasts has also recently been reported. Alternatives to the phosphomevalonate kinase and mevalonate diphosphate decarboxylase reactions may exist in archaea. Thus, new details regarding isopentenyl diphosphate synthesis from acetyl-CoA continue to emerge.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Structural mechanism for statin inhibition of HMG-CoA reductase
Istvan, E. S., & Deisenhofer, J. (2001) · Science · doi:10.1126/science.1059344 · Cited by 1,644
THE STRUCTURAL BIOLOGY OF TYPE II FATTY ACID BIOSYNTHESIS
White, S. W., Zheng, J., Zhang, Y.-M., & Rock, C. O. (2005) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.74.082803.133524 · Cited by 832
Endo, A., Kuroda, M., & Tanzawa, K. (1976) · FEBS Letters · doi:10.1016/0014-5793(76)80996-9 · Cited by 794
Biosynthesis of isoprenoids via the non-mevalonate pathway
Eisenreich, W., Bacher, A., Arigoni, D., & Rohdich, F. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-3381-z · Cited by 668
The Biological Synthesis of Cholesterol
Bloch, K. (1965) · Science · doi:10.1126/science.150.3692.19 · Cited by 560
Istvan, E. S., Palnitkar, M., Buchanan, S. K., & Deisenhofer, J. (2000) · The EMBO Journal · doi:10.1093/emboj/19.5.819 · Cited by 324
Liscum, L., Finer-Moore, J., Stroud, R. M., Luskey, K. L., Brown, M. S., & Goldstein, J. L. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)89764-2 · Cited by 308
Wilding, E. I., Brown, J. R., Bryant, A. P., Chalker, A. F., Holmes, D. J., Ingraham, K. A., Iordanescu, S., So, C. Y., Rosenberg, M., & Gwynn, M. N. (2000) · Journal of Bacteriology · doi:10.1128/jb.182.15.4319-4327.2000 · Cited by 262
Mevalonic Acid Pyrophosphate and Isopentenylpyrophosphate
Bloch, K., Chaykin, S., Phillips, A. H., & de Waard, A. (1959) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)69744-3 · Cited by 221
Biosynthesis of Isoprenoids via Mevalonate in Archaea: The Lost Pathway
Smit, A., & Mushegian, A. (2000) · Genome Research · doi:10.1101/gr.145600 · Cited by 169
Cited by
Ferroptosis: Mechanisms and links with diseases
Yan, H.-F., Zou, T., Tuo, Q.-Z., Xu, S., Li, H., Belaidi, A. A., & Lei, P. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00428-9 · Cited by 1,471
“MVA is then converted into isopentenyl-diphosphate (IPP) through a series of enzymatic steps, which serves as a monomeric unit for the consequent synthesis of all downstream metabolites.(136) IPP is catalyzed into CoQ10 through various enzymatic steps,(137) including two major intermediates, farnesyl diphosphate (FPP)…”
BackgroundNetwork Analysis of the MVA and MEP Pathways for Isoprenoid Synthesis
Vranová, E., Coman, D., & Gruissem, W. (2013) · Annual Review of Plant Biology · doi:10.1146/annurev-arplant-050312-120116 · Cited by 1,160
Carotenoids in Algae: Distributions, Biosyntheses and Functions
Takaichi, S. (2011) · Marine Drugs · doi:10.3390/md9061101 · Cited by 802
The interplay between cell signalling and the mevalonate pathway in cancer
Mullen, P. J., Yu, R., Longo, J., Archer, M. C., & Penn, L. Z. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.76 · Cited by 699
Pyrin inflammasome activation and RhoA signaling in the autoinflammatory diseases FMF and HIDS
Park, Y. H., Wood, G., Kastner, D. L., & Chae, J. J. (2016) · Nature Immunology · doi:10.1038/ni.3457 · Cited by 586
Biologically Active Secondary Metabolites from the Fungi
Bills, G. F., & Gloer, J. B. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.funk-0009-2016 · Cited by 438
The Concise Guide to PHARMACOLOGY 2013/14: Enzymes
Alexander, S. P. H., Benson, H. E., Faccenda, E., Pawson, A. J., Sharman, J. L., Spedding, M., Peters, J. A., Harmar, A. J., & Collaborators, C. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12451 · Cited by 425
Terpene Biosynthesis: Modularity Rules
Oldfield, E., & Lin, F. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201103110 · Cited by 391
Traversing the fungal terpenome
Quin, M. B., Flynn, C. M., & Schmidt-Dannert, C. (2014) · Nat. Prod. Rep. · doi:10.1039/c4np00075g · Cited by 362
Yeast lipid metabolism at a glance
Klug, L., & Daum, G. (2014) · FEMS Yeast Research · doi:10.1111/1567-1364.12141 · Cited by 349
Carotenoids, versatile components of oxygenic photosynthesis
Domonkos, I., Kis, M., Gombos, Z., & Ughy, B. (2013) · Progress in Lipid Research · doi:10.1016/j.plipres.2013.07.001 · Cited by 308
Eight Kinetically Stable but Thermodynamically Activated Molecules that Power Cell Metabolism
Walsh, C. T., Tu, B. P., & Tang, Y. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00510 · Cited by 303
Carotenoids from Marine Microalgae: A Valuable Natural Source for the Prevention of Chronic Diseases
Raposo, M., De Morais, A., & De Morais, R. (2015) · Marine Drugs · doi:10.3390/md13085128 · Cited by 228
Recent Advances in Ergosterol Biosynthesis and Regulation Mechanisms in Saccharomyces cerevisiae
Hu, Z., He, B., Ma, L., Sun, Y., Niu, Y., & Zeng, B. (2017) · Indian Journal of Microbiology · doi:10.1007/s12088-017-0657-1 · Cited by 225
Natural products as biofuels and bio-based chemicals: fatty acids and isoprenoids
Beller, H. R., Lee, T. S., & Katz, L. (2015) · Natural Product Reports · doi:10.1039/c5np00068h · Cited by 153
Bing, J., Hu, T., Zheng, Q., Muñoz, J. F., Cuomo, C. A., & Huang, G. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01466-20 · Cited by 86
“ERG13 encodes a hydroxymethylglutaryl coenzyme A (hydroxymethylglutaryl-CoA) synthase to yield 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) (36).”
BackgroundThe Impacts of Microgravity on Bacterial Metabolism
Sharma, G., & Curtis, P. D. (2022) · Life · doi:10.3390/life12060774 · Cited by 64
Toxicity of Naturally Occurring Anthraquinones
Shukla, V., Asthana, S., Gupta, P., Dwivedi, P. D., Tripathi, A., & Das, M. (2017) · Advances in Molecular Toxicology · doi:10.1016/b978-0-12-812522-9.00001-4 · Cited by 42
Fukuma, Y., Matsui, H., Koike, H., Sekine, Y., Shechter, I., Ohtake, N., Nakata, S., Ito, K., & Suzuki, K. (2012) · Prostate Cancer and Prostatic Diseases · doi:10.1038/pcan.2012.14 · Cited by 39
Wang, Y., Tian, Y., Xu, D., Cheng, S., Li, W.-W., & Song, H. (2025) · Biotechnology Advances · doi:10.1016/j.biotechadv.2025.108516 · Cited by 17
Metadata
- Authors
- Miziorko, H. M.
- Venue
- Archives of Biochemistry and Biophysics
- Publisher
- Elsevier BV
- Published
- 2011-01
- Volume
- 505
- Issue
- 2
- Pages
- 131-143
- ISSN
- 0003-9861 (ISSN-L)
- OpenAlex
- W1994675489
- Cited by
- 506
- References
- 54
- FWCI
- 8.15
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.